Creative Medical Technology Holdings, In - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CELZ Nasdaq 2830 www.creativemedicaltechnology.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Creative Medical Technology Holdings, In

Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline - Feb 10th, 2026 7:00 am
Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain - Jan 13th, 2026 7:15 am
Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative - Jan 6th, 2026 7:15 am
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point - Dec 17th, 2025 7:15 am
Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201 - Dec 2nd, 2025 7:15 am
Bears are Losing Control Over Creative Medical Technology Holdings, Inc. (CELZ), Here's Why It's a 'Buy' Now - Nov 5th, 2025 7:55 am
Market Sentiment Around Loss-Making Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) - Oct 31st, 2025 4:39 am
Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits - Oct 30th, 2025 7:15 am
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds - Oct 29th, 2025 7:00 am
Creative Medical Technology Holdings Issues Letter to Shareholders - Oct 27th, 2025 6:15 am
Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs - Oct 7th, 2025 7:15 am
Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain - Aug 13th, 2025 7:01 am
Creative Medical Technology Holdings Second Quarter 2025 Earnings: US$0.48 loss per share (vs US$1.11 loss in 2Q 2024) - Aug 11th, 2025 4:01 am
New Strong Sell Stocks for July 31st - Jul 31st, 2025 3:43 am
Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells - Jul 17th, 2025 7:15 am
Creative Medical Technology Holdings Receives Notice of Allowance for ImmCelz™ for Treatment of Heart Failure and/or Post Infarct Pathological Remodeling - Jul 11th, 2025 6:01 am
Companies Like Creative Medical Technology Holdings (NASDAQ:CELZ) Are In A Position To Invest In Growth - Apr 27th, 2025 7:41 am
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain - Mar 20th, 2025 5:50 am
Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) Shift From Loss To Profit - Mar 16th, 2025 8:14 am